130 related articles for article (PubMed ID: 15614736)
21. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate.
Bocker T; Bittinger A; Wieland W; Buettner R; Fauser G; Hofstaedter F; Rüschoff J
Mod Pathol; 1995 Apr; 8(3):226-31. PubMed ID: 7542384
[TBL] [Abstract][Full Text] [Related]
22. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.
Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI
Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557
[TBL] [Abstract][Full Text] [Related]
23. Cellular distribution of retinoic acid receptor-alpha in benign hyperplastic and malignant human prostates: comparison with androgen, estrogen and progesterone receptor status.
Gyftopoulos K; Sotiropoulou G; Varakis I; Barbalias GA
Eur Urol; 2000 Sep; 38(3):323-30. PubMed ID: 10940708
[TBL] [Abstract][Full Text] [Related]
24. Distribution of prostasomes in neoplastic epithelial prostate cells.
Nilsson BO; Egevad L; Jin M; Ronquist G; Busch C
Prostate; 1999 Apr; 39(1):36-40. PubMed ID: 10221264
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment.
Guate JL; Escaf S; Menendez CL; del Valle M; Vega JA
Urol Int; 1997; 59(3):149-53. PubMed ID: 9428430
[TBL] [Abstract][Full Text] [Related]
26. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.
Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J
Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004
[TBL] [Abstract][Full Text] [Related]
27. Metachromasia in the human prostate: a histochemical difference between benign prostatic hyperplasia and prostatic carcinoma.
Arcadi JA
J Urol; 1988 Feb; 139(2):315-7. PubMed ID: 2448498
[TBL] [Abstract][Full Text] [Related]
28. Expression of KAI1 in paraffin-embedded normal, hyperplastic and neoplastic prostate and prostate carcinoma cell lines.
Ward JM; Konishi N; Ohshima M; Lamb PW; Jorcyk CL; Barrett JC
Pathol Int; 1998 Feb; 48(2):87-92. PubMed ID: 9589471
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
30. Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens.
Kaleem Z; Swanson PE; Vollmer RT; Humphrey PA
Am J Clin Pathol; 1998 Jun; 109(6):695-703. PubMed ID: 9620026
[TBL] [Abstract][Full Text] [Related]
31. Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.
Habermann H; Ray V; Habermann W; Prins GS
J Urol; 2002 Feb; 167(2 Pt 1):655-60. PubMed ID: 11792947
[TBL] [Abstract][Full Text] [Related]
32. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.
Richardsen E; Ukkonen T; Bjørnsen T; Mortensen E; Egevad L; Busch C
Virchows Arch; 2003 Apr; 442(4):329-35. PubMed ID: 12684767
[TBL] [Abstract][Full Text] [Related]
34. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma.
Friedrich B; Grönberg H; Landström M; Gullberg M; Bergh A
Prostate; 1995 Aug; 27(2):102-9. PubMed ID: 7638082
[TBL] [Abstract][Full Text] [Related]
35. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.
Padmanabhan V; Callas P; Philips G; Trainer TD; Beatty BG
J Clin Pathol; 2004 Oct; 57(10):1057-62. PubMed ID: 15452160
[TBL] [Abstract][Full Text] [Related]
36. Prostatic adenocarcinoma. Evaluation of immunoreactivity to monoclonal antibody B72.3.
Mazur MT; Shultz JJ
Am J Clin Pathol; 1990 Apr; 93(4):466-70. PubMed ID: 2321578
[TBL] [Abstract][Full Text] [Related]
37. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.
Amirghofran Z; Monabati A; Gholijani N
Pathol Oncol Res; 2004; 10(1):37-41. PubMed ID: 15029260
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
40. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
